SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study

Recruiting N/A Interventional Study
Schizophrenia Spectrum and Other Psychotic Disorders Affective Psychoses
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
150 (estimated)
Sponsor
King's College London · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Worries about harm from others (also known as paranoia) are common. Thinking fast or going on gut feelings is natural but can fuel these worries. For some, fast thinking and worries start to get in the way of life. Cognitive behaviour therapy for psychosis (CBTp) is the recommended talking therapy. However, only a minority of people can access CBTp due to limited resources, and even when available…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Meet criteria for ICD-10 psychosis diagnoses (F20-29, F30-39) * Seeking therapy for paranoia * In contact with secondary care mental health services * Capacity to provide informed consent to engage in therapy Exclusion Criteria: * Acute risk of harm to self or others * Unabl…
Contacts

Kathryn M Taylor

07876876164

kathryn.taylor@kcl.ac.uk

CONTACT